Van Laethem K - Search Results

1

HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure.

Sangeda RZ, Theys K, Beheydt G, Rhee SY, Deforche K, Vercauteren J, Libin P, Imbrechts S, Grossman Z, Camacho RJ, Van Laethem K, Pironti A, Zazzi M, Sönnerborg A, Incardona F, De Luca A, Torti C, Ruiz L, Van de Vijver DA, Shafer RW, Bruzzone B, Van Wijngaerden E, Vandamme AM; Virolab and EuResist Projects. Sangeda RZ, et al. Among authors: van laethem k, van wijngaerden e, van de vijver da. Infect Genet Evol. 2013 Oct;19:349-60. doi: 10.1016/j.meegid.2013.03.014. Epub 2013 Mar 21. Infect Genet Evol. 2013. PMID: 23523594 Free article.

2

The three human T-lymphotropic virus type I subtypes arose from three geographically distinct simian reservoirs.

Liu HF, Goubau P, Van Brussel M, Van Laethem K, Chen YC, Desmyter J, Vandamme AM. Liu HF, et al. Among authors: van laethem k, van brussel m. J Gen Virol. 1996 Feb;77 ( Pt 2 ):359-68. doi: 10.1099/0022-1317-77-2-359. J Gen Virol. 1996. PMID: 8627240

3

Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test.

Vandamme AM, Schmit JC, Van Dooren S, Van Laethem K, Gobbers E, Kok W, Goubau P, Witvrouw M, Peetermans W, De Clercq E, Desmyter J. Vandamme AM, et al. Among authors: van laethem k, van dooren s. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Oct 1;13(2):127-39. doi: 10.1097/00042560-199610010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8862277

4

Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology.

Vandamme AM, Van Laethem K, Liu HF, Van Brussel M, Delaporte E, de Castro Costa CM, Fleischer C, Taylor G, Bertazzoni U, Desmyter J, Goubau P. Vandamme AM, et al. Among authors: van laethem k, van brussel m. J Med Virol. 1997 May;52(1):1-7. J Med Virol. 1997. PMID: 9131450

5

Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein.

Este JA, Schols D, De Vreese K, Van Laethem K, Vandamme AM, Desmyter J, De Clercq E. Este JA, et al. Among authors: van laethem k. Mol Pharmacol. 1997 Jul;52(1):98-104. doi: 10.1124/mol.52.1.98. Mol Pharmacol. 1997. PMID: 9224818

6

Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users.

Salemi M, Vandamme AM, Gradozzi C, Van Laethem K, Cattaneo E, Taylor G, Casoli C, Goubau P, Desmyter J, Bertazzoni U. Salemi M, et al. Among authors: van laethem k. J Mol Evol. 1998 May;46(5):602-11. doi: 10.1007/pl00006340. J Mol Evol. 1998. PMID: 9545470

7

Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain.

Debyser Z, Van Wijngaerden E, Van Laethem K, Beuselinck K, Reynders M, De Clercq E, Desmyter J, Vandamme AM. Debyser Z, et al. Among authors: van laethem k, van wijngaerden e. AIDS Res Hum Retroviruses. 1998 Mar 20;14(5):453-9. doi: 10.1089/aid.1998.14.453. AIDS Res Hum Retroviruses. 1998. PMID: 9546805

8

African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Vandamme AM, Salemi M, Van Brussel M, Liu HF, Van Laethem K, Van Ranst M, Michels L, Desmyter J, Goubau P. Vandamme AM, et al. Among authors: van laethem k, van brussel m, van ranst m. J Virol. 1998 May;72(5):4327-40. doi: 10.1128/JVI.72.5.4327-4340.1998. J Virol. 1998. PMID: 9557723 Free PMC article.

9

Diagnosis of human immunodeficiency virus infection by a polymerase chain reaction assay evaluated in patients harbouring strains of diverse geographical origin.

Van Laethem K, Beuselinck K, Van Dooren S, De Clercq E, Desmyter J, Vandamme AM. Van Laethem K, et al. Among authors: van dooren s. J Virol Methods. 1998 Feb;70(2):153-66. doi: 10.1016/s0166-0934(97)00178-x. J Virol Methods. 1998. PMID: 9562409

10

Comparison of the LiPA HIV-1 RT test, selective PCR and direct solid phase sequencing for the detection of HIV-1 drug resistance mutations.

Schmit JC, Ruiz L, Stuyver L, Van Laethem K, Vanderlinden I, Puig T, Rossau R, Desmyter J, De Clercq E, Clotet B, Vandamme AM. Schmit JC, et al. Among authors: van laethem k. J Virol Methods. 1998 Jul;73(1):77-82. doi: 10.1016/s0166-0934(98)00043-3. J Virol Methods. 1998. PMID: 9705178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page